Resmed Inc. buy JPMorgan Chase & Co.
Start price
09.01.24
/
50%
€164.95
Target price
09.01.25
€178.27
Performance (%)
38.22%
End price
10.01.25
€228.00
Summary
This prediction ended on 10.01.25 with a price of €228.00. With a performance of 38.22% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.87 was paid as dividends for this prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.512% | -2.512% | -9.382% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $195.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten